Stoke Therapeutics Inc (STOK)
12.02
+0.33
(+2.82%)
USD |
NASDAQ |
May 03, 16:00
12.00
-0.02
(-0.17%)
After-Hours: 20:00
Stoke Therapeutics 1 Year Total Returns (Daily): 26.66% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 26.66% |
May 02, 2024 | 18.80% |
May 01, 2024 | 17.12% |
April 30, 2024 | 24.07% |
April 29, 2024 | 33.41% |
April 26, 2024 | 38.35% |
April 25, 2024 | 44.14% |
April 24, 2024 | 43.95% |
April 23, 2024 | 29.61% |
April 22, 2024 | 29.61% |
April 19, 2024 | 33.74% |
April 18, 2024 | 35.31% |
April 17, 2024 | 29.65% |
April 16, 2024 | 52.39% |
April 15, 2024 | 49.45% |
April 12, 2024 | 58.83% |
April 11, 2024 | 66.87% |
April 10, 2024 | 60.91% |
April 09, 2024 | 61.43% |
April 08, 2024 | 63.32% |
April 05, 2024 | 58.31% |
April 04, 2024 | 51.37% |
April 03, 2024 | 55.90% |
April 02, 2024 | 57.02% |
April 01, 2024 | 61.94% |
Date | Value |
---|---|
March 28, 2024 | 68.12% |
March 27, 2024 | 77.57% |
March 26, 2024 | 34.51% |
March 25, 2024 | -15.03% |
March 22, 2024 | -21.15% |
March 21, 2024 | -27.83% |
March 20, 2024 | -26.68% |
March 19, 2024 | -34.98% |
March 18, 2024 | -31.84% |
March 15, 2024 | -30.16% |
March 14, 2024 | -34.08% |
March 13, 2024 | -28.20% |
March 12, 2024 | -24.14% |
March 11, 2024 | -17.39% |
March 08, 2024 | -17.00% |
March 07, 2024 | -17.12% |
March 06, 2024 | -13.74% |
March 05, 2024 | -19.25% |
March 04, 2024 | -22.37% |
March 01, 2024 | -12.70% |
February 29, 2024 | -12.94% |
February 28, 2024 | -10.46% |
February 27, 2024 | -5.77% |
February 26, 2024 | -22.13% |
February 23, 2024 | -32.65% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-78.27%
Minimum
Oct 27 2023
200.3%
Maximum
Mar 16 2021
-13.04%
Average
-37.40%
Median
Aug 05 2022
1 Year Total Returns (Daily) Benchmarks
NeuBase Therapeutics Inc | -88.23% |
iBio Inc | -90.87% |
Actinium Pharmaceuticals Inc | -0.11% |
Lixte Biotechnology Holdings Inc | -47.55% |
Fate Therapeutics Inc | -35.76% |